United Therapeutics to buy back $250M in shares

|About: United Therapeutics Co... (UTHR)|By:, SA News Editor

The board of United Therapeutics (NASDAQ:UTHR) authorizes the repurchase of up to $250M of the company's common shares through the end of the year.

Chairman & CEO Martine Rothblatt, Ph.D. says, "We are pleased to continue our track record of returning value to our shareholders via stock repurchases. When this new repurchase program is completed, we will have returned over $2.0 billion to our shareholders over a six-year period, repurchasing more than 35% of our outstanding shares during that time."